We are live on ! Find out more
TOVX icon

Theriva Biologics
TOVX

15 hedge funds and large institutions have $23.3M invested in Theriva Biologics in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $23.1M → $23.3M (+$205K)

0% more funds holding

Funds holding: 15 → 15 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
1
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$481K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$261K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$48K
2
U
UBS
Switzerland
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$16.5M – – –
MP
2
MSD Partners
New York
$3.53M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$827K +$261K +19 +51%
RA
4
Royce & Associates
New York
$720K – – –
Janney Montgomery Scott
5
Janney Montgomery Scott
Pennsylvania
$508K +$481K +35 New
Bank of America
6
Bank of America
North Carolina
$400K – – –
California Public Employees Retirement System
7
California Public Employees Retirement System
California
$169K – – –
Geode Capital Management
8
Geode Capital Management
Massachusetts
$165K – – –
BCM
9
Bridgeway Capital Management
Texas
$134K – – –
BFA
10
BlackRock Fund Advisors
California
$106K – – –
Morgan Stanley
11
Morgan Stanley
New York
$79K – – –
WTNA
12
Wilmington Trust National Association
Delaware
$61K – – –
Northern Trust
13
Northern Trust
Illinois
$59K – – –
HLA
14
Hamilton Lane Advisors
Pennsylvania
$40K – – –
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
$25K – – –
Citigroup
16
Citigroup
New York
$3K – – –
Creative Planning
17
Creative Planning
Kansas
$2K – – –
Manulife (Manufacturers Life Insurance)
18
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
Wells Fargo
19
Wells Fargo
California
– -$48K -3 Closed
U
20
UBS
Switzerland
– -$3K – –

TOVX Hedge Fund Activity: Q3 2013 in Review

15 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Theriva Biologics (TOVX) for Q3 2013, worth a combined $23.3M — up 0.89% from $23.1M a quarter earlier.

Fund positioning in TOVX was balanced in Q3 2013: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Janney Montgomery Scott, opening a new position worth an estimated $481K. The largest seller was Wells Fargo, exiting entirely with an estimated $48K sold.

  • 15 institutional investors held Theriva Biologics (TOVX) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $23.3M of Theriva Biologics stock for Q3 2013, up 0.89% quarter-over-quarter.
  • 1 fund opened new Theriva Biologics positions in Q3 2013 and 1 closed out, a net change of 0 holders.
  • The largest Theriva Biologics buyer in Q3 2013 was Janney Montgomery Scott, an estimated $481K added.
  • The largest Theriva Biologics seller in Q3 2013 was Wells Fargo, an estimated $48K sold.

Based on aggregated 13F filings for Q3 2013.